PAVmed (PAVM) Cash from Financing Activities (2015 - 2025)

PAVmed's Cash from Financing Activities history runs 10 years deep, the most recent figure standing at -$2000.0 for Q3 2025.

• In Q3 2025, Cash from Financing Activities changed N/A year-over-year to -$2000.0; the TTM figure through Dec 2025 stood at $5.6 million (down 84.6% YoY), while the FY2025 annual figure was $5.6 million, down 82.13% from the prior year.
• Cash from Financing Activities for Q3 2025 stood at -$2000.0, down from $2.5 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $60.1 million in Q4 2021, with the low at -$2000.0 in Q3 2025.
• The 5-year median for Cash from Financing Activities is $2.8 million (2025), against an average of $11.7 million.
• The sharpest annual moves came in 2022 and 2023: Cash from Financing Activities tumbled 99.87% in 2022, then surged 7787.34% in 2023.
• PAVmed's Cash from Financing Activities stood at $60.1 million in 2021, then sank by 99.87% to $80000.0 in 2022, then jumped by 6510.0% to $5.3 million in 2023, then slumped by 93.76% to $330000.0 in 2024, then tumbled by 100.61% to -$2000.0 in 2025.
• Business Quant data shows PAVM's Cash from Financing Activities at -$2000.0 in Q3 2025, $2.5 million in Q2 2025, and $3.1 million in Q1 2025.